| Management target | Revenue 10.0% FY27 |
|---|
| Revenue growth | Value up 8.1%, volume up 5.3% excluding discontinued brands. |
|---|---|
| Margins | EBITDA margin at 8.4%, down 820 basis points YoY. |
| Demand visibility | Rural demand resilient; urban demand remains subdued due to inflation. |
| Management confidence | Cautiously optimistic tone despite reporting significant margin contraction. |
Growth
Organic value growth was 8.1% and volume growth 5.3%, offset by raw material cost inflation hitting 30-35%.
Outlook
Expecting double-digit revenue growth in FY27 with H2 margins substantially better than H1.
Risks
90% business exposure to crude derivatives; competitors reducing prices creates structural deflationary pressure on margins.
Last quarter's promises, checked
Delivered
- Guided HI segment to turn profitable → delivered losses reduced from 25Cr to 5Cr (= BEAT)
- Guided for retail expansion → delivered 1 lakh new outlets added (= BEAT)
- Guided for liquid detergent growth → delivered liquids nearly doubled in FY26 (= BEAT)
Partly delivered
- Guided for M&A activity → delivered 'active dialogues' but no deal closed (= PARTIAL)
Missed
- Guided EBITDA margin stability → delivered 13.5% vs 16.8% YoY (= MISS)
- Guided gross margin protection → delivered 45.2% vs 49.2% YoY (= MISS)
- Guided A&P spend levels → delivered 7% vs 8% previous year (= MISS)
Earnings Call Transcript filed with BSE, NSE: JYOTHYLAB. Summary written with AI assistance from the document.
Jyothy Labs Ltd: key numbers
- Share price
- ₹191.07
- Market cap
- ₹7,016 Cr
- Revenue (annual)
- ₹2,944 Cr
- Net profit (annual)
- ₹333.2 Cr
- P/E (TTM)
- 24.7×Sector 43.4×
- Promoter holding
- 62.89%+0.00% QoQ
- FII holding
- 12.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jyothy Labs Ltd
All →Jyothy Labs Credit Rating
CARE Ratings has reaffirmed Jyothy Labs Limited's 'CARE AA; Stable' rating for its long-term bank facilities. The rating applies to facilities totaling Rs. 250 crore.
- Value
- ₹250.0 Cr
Jyothy Labs Employee Stock Options
Jyothy Labs has granted 1,46,141 Restricted Stock Units (RSUs) to eligible employees under its RSU Plan 2023. These units vest over a period of up to four years.
Jyothy Labs Capital Structure Change
Nalanda India Equity Fund Limited acquired a 0.85% stake in Jyothy Laboratories Limited. The acquisition of 3,102,384 shares increases the fund's total holding to 7.61%.
Jyothy Labs Other Announcement
Jyothy Labs has been assigned an ESG rating of '67' by NSE Sustainability Ratings & Analytics Limited. This rating was derived independently using public domain data.
Jyothy Labs Investor Presentation: Key Takeaways
Jyothy Labs reported 3% revenue growth for Q1 FY27, driven by Fabric Care. EBITDA and PAT saw significant declines of 47.9% and 50.8% respectively due to abnormal raw material and packaging inflation.
Jyothy Labs Q1 FY27 Results: Net Profit ₹47.6 Cr, Down 50.8% YoY
Jyothy Labs Ltd reported revenue from operations of ₹773.4 Cr (+3.0% YoY) and net profit of ₹47.6 Cr (-50.8% YoY) for Q1 FY27.
- Key figure
- Net profit ₹47.6 Cr · -50.8% YoY